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Abstract
Iatrogenic colonoscopy perforation (ICP) is a severe complication that can occur during both diagnostic and therapeutic
procedures. Although 45–60% of ICPs are diagnosed by the endoscopist while performing the colonoscopy, many ICPs
are not immediately recognized but are instead suspected on the basis of clinical signs and symptoms that occur after
the endoscopic procedure. There are three main therapeutic options for ICPs: endoscopic repair, conservative therapy,
and surgery. The therapeutic approach must vary based on the setting of the diagnosis (intra- or post-
colonoscopy), the type of ICP, the characteristics and general status of the patient, the operator’s level of experience, and
surgical device availability.
Although ICPs have been the focus of numerous publications, no guidelines have been created to standardize
the management of ICPs. The aim of this article is to present the World Society of Emergency Surgery (WSES)
guidelines for the management of ICP, which are intended to be used as a tool to promote global standards of
care in case of ICP. These guidelines are not meant to substitute providers’ clinical judgment for individual
patients, and they may need to be modified based on the medical team’s level of experience and the availability
of local resources.
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Background
Iatrogenic colonic perforations (ICPs) are an infrequent but
severe complication of colonoscopy. Globally, the incidence
is estimated to be 0.016–0.8% for diagnostic colonoscopies
and 0.02–8% for therapeutic colonoscopies [1–10], but
considering the increasing numbers of screening, diagnos-
tic, and therapeutic colonoscopies being performed every
year, the frequency of ICP is not insignificant [11, 12].
Approximately 45–60% of ICPs are detected by the
endoscopist while performing the colonoscopy, although
a considerable number of ICPs are not recognized
immediately, but rather are suspected on the basis of
clinical signs and symptoms occurring after the endo-
scopic procedure. In this latter case, colonic perforations
may lead to the development of secondary peritonitis,
which is associated with significant morbidity and
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mortality [5, 13–18]. Depending on the delay in the man-
agement of the ICP and the pre-existing pathologies, ICP-
related mortality is as high as 5–25% [5, 14–16, 18–22].
One of the most important issues in the management of
ICPs is the time period between the diagnosis and the
treatment. There are different treatment alternatives for
ICP, including conservative, endoscopic, and surgical
approaches. The therapeutic strategy varies based on the
setting in which the ICP is diagnosed (i.e., intra- or post-
colonoscopy), the specific characteristics of the perforation
(e.g., size, location, and etiology), the patient’s general sta-
tus, and the skill level of the operator [8, 23, 24]. Although
ICPs have been the subject of numerous publications, no
randomized clinical trials have been conducted to evaluate
the best treatment option and no guidelines have been
defined to standardize its management. For this reason,
the World Society of Emergency Surgery (WSES)
convened a consensus conference to review the available
literature, discuss the current controversies, and create
guidelines for the management of ICP. The present article
is the summary of the WSES consensus conference,
including (1) the incidence of and risk factors for ICP, (2)
the diagnosis of ICP, (3) the conservative and endoscopic
treatments for ICP, (4) the surgical treatments for ICP, and
(5) the follow-up after ICP treatment. Based upon the
evidence emerging from the consensus conference, a
decision-making algorithm was developed to guide
clinicians and surgeons through the different medical,
endoscopic, and surgical treatments for ICP.
Materials and methods: expert panel and
consensus conference organization
On September 2016, the President of the WSES (Luca
Ansaloni) appointed five WSES members (Nicola
de’Angelis, Fausto Catena, Federico Coccolini, Salo-
mone Di Saverio, Massimo Sartelli) to establish the
project committee and determine the organization of
an international multidisciplinary expert panel deputed
to develop the WSES Guidelines for the management
of ICP. The project committee agreed to develop prac-
tice guidelines by formal consensus, which consists of
formalizing the degree of agreement among experts by
identifying and selecting, through ratings and feedback,
the points on which the experts agree and the points
on which they disagree or are undecided. Additionally,
it involves drafting a small number of concise and
unambiguous recommendations that address the
questions asked.
Briefly, the development of the WSES guidelines
was structured upon two phases: the synthesis of the
literature and the consensus conference. For phase I,
the project committee identified 17 key questions re-
garding ICP risk, diagnosis, and treatments that
would guide the literature search (Table 1). Then, an
expert panel composed of surgeons, endoscopists,
gastroenterologists, and anesthesiologists from five
continents was invited to participate and answer the
selected questions. The experts who agreed to partici-
pate (n = 50) were divided into 17 groups of at least 3
experts each who were asked to answer one of the
selected key questions regarding ICP. For each group,
a group leader was nominated; the group leader was
Table 1 Key questions used to develop the Consensus
Conference on iatrogenic colonoscopy perforation (ICP)
Risk of ICP
Q1 What are the general recommendations to minimize the risk of
ICP during screening and therapeutic colonoscopies?
Q2 What is the maximum incidence of ICP considered acceptable
for centers where diagnostic or therapeutic colonoscopies are
performed?
Diagnosis of ICP
Q3 What is the minimum information the endoscopist must report
after diagnosing an ICP during a colonoscopy procedure?
Q4 What are the minimum biochemical and imaging investigations
that should be requested in the case of suspected ICP?
Conservative and endoscopic treatments of ICP
Q5 What are the indications for a conservative treatment or an
immediate surgical intervention after an ICP diagnosis?
Q6 What is the minimum duration of the hospital observation
period for patients who have undergone successful endoscopic
closure or conservative management of ICP?
Q7 What investigations (clinical, biochemical, and imaging) should
be performed during the observation period in patients who
have undergone successful endoscopic closure or conservative
management of ICP?
Q8 What is the recommended type and duration of antibiotic
therapy in patients who have undergone successful endoscopic
closure or conservative management of ICP?
Q9 What is the recommended type and duration of antithrombotic
prophylaxis in patients who have undergone successful
endoscopic closure or conservative management of ICP?
Q10 How long is the fasting time in patients who have undergone
successful endoscopic closure or conservative treatments
for ICP?
Surgical treatment of ICP
Q11 Is explorative laparoscopy indicated in all patients with ICP?
Q12 What are the indications for conversion from laparoscopy to
open surgery in patients with surgical ICP?
Q13 What are the key factors when choosing the best surgical
approach for ICP?
Q14 What are the indications for performing a diverting or terminal
stoma in patients with ICP?
Q15 What are the indications for drainages in patients with ICP?
Q16 What are the indications for the use of damage control surgery
in patients with ICP?
Follow-up of ICP
Q17 Is there any recommendation to perform a surveillance
endoscopy after a successful ICP treatment? If so, what is the
recommended timing for it?
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responsible for coordinating the work of the experts
in his/her group, providing a summary document that
aligned the group’s agreement upon answers to the
specific question assigned, and meeting the assigned
deadline. Experts were solicited to search the litera-
ture using a systematic approach within different
databases (e.g., PubMed, EMBASE, and Scopus) and
assess the level of evidence and the grade of the
recommendation based on the recommendations of
Guyatt et al. [25] (Table 2). For the literature search,
the following keywords and MeSH terms were used:
management of colonic/colon perforations, repair of
iatrogenic large bowel perforations, abdominal
imaging in colonic perforations, evolution of imaging,
colonic perforation complications/outcomes, endo-
scopic treatment of colonic perforations, and periton-
itis after colonoscopy.
Within each group, a scientific discussion ensued via
email, and modifications were implemented when neces-
sary based on feedback, consistent evidence from the
literature, and, whenever pertinent, clinical experience
(empirical evidence). The answers provided for each
question constituted the provisional statements about
the management of ICP that were submitted for review
to all participants at the consensus conference (phase
II). The Consensus Conference on ICP management was
held in Campinas, Brazil, on May 20, 2017, during the
4th WSES World Congress. During the first part of the
consensus conference, the group leaders presented the
results of their group discussion with the answer to the
key question assigned, the provisional statements along
with the supporting literature, the level of evidence, and
the grade of the recommendation. Each statement was
then discussed and voted on by the audience. The
percentage of agreement was recorded immediately; in
cases of disagreement greater than 30%, the statement
was modified after discussion. Furthermore, relevant
comments about each statement were collected and used
during the revision process. During the final portion of
the consensus conference, a comprehensive algorithm
for the management of ICP was developed based on the
results of the literature review and the plenary discus-
sion among the experts.
The revised statements, their level of evidence, and the
recommendation grade are presented below. Please note
that the WSES guidelines must be considered an
adjunctive tool in the decision-making process regarding
the management of ICP; they are not intended to substi-
tute a provider’s clinical judgment for an individual
patient, and they may need to be modified based on the
medical team’s experience and the available local
resources.
Table 2 Grading of recommendations (from Guyatt et al.)
Grade of
recommendation
Description Benefits vs. risks Quality of supporting evidence Implications
1A Strong
recommendation,
high-quality
evidence
Benefits clearly outweigh
risks and burdens, or vice
versa
RCTs without important limitations
or overwhelming evidence from
observational studies
Strong recommendation, applies to
most patients in most circumstances
without reservation
1B Strong
recommendation,
moderate-quality
evidence
Benefits clearly outweigh risk
and burdens, or vice versa
RCTs with important limitations
(inconsistent results, methodological
flaws, indirect or imprecise) or
exceptionally strong evidence from
observational studies
Strong recommendation, applies to
most patients in most circumstances
without reservation
1C Strong
recommendation,
low-quality or
very low-quality
evidence
Benefits clearly outweigh risk
and burdens, or vice versa
Observational studies or case series Strong recommendation based on
limited evidence; recommendations
may change when higher quality or
more extensive evidence becomes
available
2A Weak
recommendation,
high-quality
evidence
Benefits closely balanced
with risks and burdens
RCTs without important limitations
or overwhelming evidence from
observational studies
Weak recommendation; best action
may differ depending on
circumstances, expertise of clinician,
the patient in question, or other
social issues
2B Weak
recommendation,
moderate-quality
evidence
Benefits closely balanced
with risks and burdens
RCTs with important limitations
(inconsistent results, methodological
flaws, indirect or imprecise) or
exceptionally strong evidence from
observational studies
Weak recommendation; best action
may differ depending on
circumstances, expertise of clinician,
the patient in question, or other
social issues
2C Weak
recommendation,
low-quality or
very low quality
evidence
Uncertainty in the estimates
of benefits, risks, and
burdens; benefits, risks, and
burdens may be closely balanced
Observational studies or case series Very weak recommendation; other
alternatives may be equally
reasonable
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Results
Incidence of and risk factors for ICP
What are the general recommendations for minimizing the
risk of ICP during screening and therapeutic colonoscopies?
There are a number of risk factors that have been related
to ICP in the literature (Table 3). Older patients are more
vulnerable to ICP, and the ages of 65, 75, and 80 years
have been shown to be independent risk factors for ICPs
[23, 26, 27]. Female gender [28, 29], low BMI [28, 30], low
albumin level, the presence of comorbidities, diverticu-
losis, Crohn’s disease, and admission to an ICU are also
acknowledged to be risk factors in several studies [20, 23,
26, 28]. The endoscopist’s level of experience may also be
considered a risk indicator, as higher incidences of ICP
have been reported for non-gastroenterologist endosco-
pists and low-volume endoscopy centers [31–33]. Finally,
anesthesia during colonoscopy has been associated with
an increased risk of ICP, in relation to the worsening of
patient’s comorbidities and the increasing technical
complexity of these procedures [34, 35].
In a recent study of 56,882 colonoscopies, full-
thickness large bowel perforation occurred in forty
patients, corresponding to an incidence rate of 0.07%
(0.05% in diagnostic/screening procedures and 0.17% in
therapeutic colonoscopies) [18]. A greater risk of ICP
was associated with low-volume practices, female gender
(due to greater colonic length and a more mobile trans-
verse colon), advanced age (reduced wall strength),
history of diverticular disease, previous abdominal
surgery (especially pelvic), and colonic obstruction (risk
of over-insufflation).
In a Spanish study of 16,285 colonoscopies, ICPs were
reported in 0.09% of cases [16]. Colonic obstruction,
prior abdominal surgery, and sigmoid diverticular
disease were indicated as potential risk factors.
A review from the Netherlands including 30,366 endo-
scopic procedures found that ICP occurred in 35 patients
(0.12%) [5]. The authors described a 4-fold higher risk of
ICP in colonoscopies compared with sigmoidoscopies and
a 5-fold greater risk of ICP in therapeutic compared with
diagnostic procedures.
A review of 10,486 colonoscopies performed in a single
institution included 20 ICPs over a period of 10 years (cor-
responding to an incidence rate of 0.19%) [29]. During the
same time interval, 46,501 flexible sigmoidoscopies were
performed and only two ICPs occurred (0.004%). Female
patients had significantly more ICPs compared with males
and, although not statistically significant, the risk of ICP
was numerically higher for endoscopists in training than
experienced endoscopists [29].
In a review of studies published between 2001 and 2009
analyzing 969,913 colonoscopies [36], the incidence of
ICP ranged from 0.032 to 0.14%. The risk factors for ICP
included age over 75 years (4- to 6-fold increase), colonos-
copy instead of sigmoidoscopy (2–4 times greater), female
gender, diverticular disease, previous abdominal surgery,
and multiple comorbidities, including diabetes mellitus,
chronic pulmonary disease, congestive heart failure,
myocardial infarction, cerebrovascular disease, peripheral
vascular disease, renal insufficiency, liver disease, and
dementia.
Therapeutic colonoscopies generally involved a higher
risk for ICP, particularly the following procedures: poly-
pectomy for large polyps, multiple polypectomies, pneu-
matic dilatation for Crohn’s stricture [37], the use of argon
plasma coagulation, and endoscopic mucosal resection
(EMR) and endoscopic submucosal dissection (ESD) for
colorectal neoplasia [38]. For endoscopic polypectomies,
the related perforation risk has been related to the size of
the polyp (larger than 10 mm in the right colon or 20 mm
in the left colon) and a sessile morphology [38], and it is
considered to be less than 1%, even when more challenging
polypectomy techniques such as EMR are performed [39].
Complex procedures such as EMR and ESD are associated
with a higher perforation incidence and should be consid-
ered to have a high risk of ICP. In 2014, a meta-analysis by
Wang et al. comparing procedure-related complications in
EMR and ESD for colorectal tumors (including 4 retro-
spective case-control studies) reported ESD-related perfo-
rations in 31/347 cases and EMR-related perforations in
33/566 cases [40]. The current literature demonstrates that
the perforation risk for ESD is decreasing in higher volume
centers to less than 5% [41, 42].
Perforation in colorectal stenting is the main early
adverse event [43]. Use of a self-expandable metal stent
Table 3 Principal risk factors for iatrogenic colonoscopy
perforations (ICP)
Risk factors References
Increasing age (> 65 years) [18, 23, 26, 27, 36]
Female gender [18, 28, 29, 36]
Low BMI [28, 29]
Low albumin level [20, 23, 26, 28]
Presence of comorbidities [18, 36]
Crohn’s disease and diverticulosis [16, 18, 20, 23, 26, 28]
Admission in ICU [20, 23, 26, 28]
Endoscopist’s experience [18, 29, 31–33]
Non-gastroenterologist endoscopists [31, 33]
Low volume centers [31, 33]
Previous abdominal surgery [16, 36]
Colonic obstruction [16, 18]
Bevacizumab therapy [44, 46, 47]
Therapeutic vs. diagnostic procedure [5, 10, 37–42, 44, 49]
Colonoscopy vs. sigmoidoscopy [5, 29, 36]
General anesthesia [34, 35]
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(SEMS) has been associated with an overall perforation
rate of 7–8% [10, 44]. In cases of acute malignant colonic
obstruction, retrospective studies have shown an SEMS-
related perforation risk of 5–9% [45]. Stenting of either
benign or neoplastic strictures has been associated with a
7.4% incidence of ICP in a recent meta-analysis [43]; the
type of stent, benign etiology, bevacizumab therapy, and
the need for re-dilation have been identified as risk factors
for ICP [44, 46, 47].
Endoscopic balloon dilation may entail perforation
rates up to 11%, even though the rate of iatrogenic per-
foration for Crohn’s disease stricture treatment is less
than 5% in the majority of retrospective studies [37, 45,
48]. Balloon dilation of rectal anastomotic strictures has
been associated with a 1.1% rate of ICP [49].
The most common site of perforation is the sigmoid
colon (53–65%), followed by the cecum, the ascending
colon, the transverse colon, the descending colon, and the
rectum [6, 13, 15, 29, 50] (Fig. 1). ICPs are generally intra-
peritoneal perforations; extra-peritoneal perforations may
manifest as pneumoretroperitoneum, pneumomediasti-
num, or subcutaneous emphysema. Combined intra- and
extra-peritoneal perforations have been reported
anecdotally [51].
There is only one randomized study concerning the risk
factors and preventive measures for ICP, whereas several
reviews of large clinical series and meta-analyses to define
the incidence and risk factors for ICP have been published
[52, 53]. Recommendations for preventive measures derive
from these studies and expert opinions [54].
Statement 1
1.1.During diagnostic endoscopy training, a low
threshold at which the senior endoscopist should
assume manual control or abort the procedure
should be established. Unusual difficulty in traversing
the sigmoid colon, a difficult examination in a female
or elderly patient, or the presence of diverticular
disease or colonic obstruction should be considered
alarming conditions (Recommendation Grade 1C).
1.2.During diagnostic or screening colonoscopies,
endoscope progression should be gently performed
and loop formation avoided. Alternative maneuvers
(e.g., compression, decubitus changes) should be used
in case of pain, but when difficulties in the
progression are observed, it is recommended to abort
the procedure (Recommendation Grade 1C).
1.3.Air should be insufflated judiciously to avoid
barotrauma, especially if bowel obstruction is
suspected. The use of CO2 further minimizes bowel
distension, abdominal discomfort, and the risk of
perforation (Recommendation Grade 1B).
1.4.During en bloc endoscopic polypectomy, the
maximum size of the tissue sample safely included in
the SNARE should be 2 cm (especially if the lesion is
proximal to the splenic flexure). Pre-polypectomy
submucosal injection reduces the risk of electro-coa-
gulative damage to the muscularis propria. Blended
current mode limits the depth of tissue damage, and
cold techniques are preferred for small polyps
(≤5 mm) (Recommendation Grade 1C).
1.5.Endoscopic submucosal dissection (ESD) should be
limited to selected cases because of the high rate of
associated complications (Recommendation Grade
1C).
1.6.Stenting of a malignant disease should be
discouraged in patients receiving bevacizumab. In the
case of Crohn’s disease, dilatation of a long stenotic
area in the presence of active disease or a suspected
fistula before or after stent placement is not advisable
(Recommendation Grade 1C).
1.7.Whenever risky endoscopic procedures must be
performed, the availability of and close collaboration
with a hospital-based multidisciplinary team can
improve patient outcomes (Recommendation Grade
1C).
What is the maximum incidence of ICP considered
acceptable for centers where diagnostic or therapeutic
colonoscopies are performed?
Colonoscopy has been demonstrated to be the most cost-
effective method for colorectal cancer screening. As the
number of procedures performed worldwide is increasing,
gastrointestinal professional societies have adopted strict
safety standards for endoscopic practice, including the
monitoring and auditing of complications to detect per-
formance gaps and continuously improve the safety of col-
onoscopy [55]. The American Society for Gastrointestinal
Endoscopy (ASGE)/American College of Gastroenterology
(ACG) Task Force on Quality in Endoscopy recommends
that post-colonoscopy perforation rates should be main-
tained at ≤ 1 per 500 colonoscopies (≤ 1/1000 in screening
Fig. 1 Location and frequency of iatrogenic colonoscopy perforation
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healthy subjects) [56]. For screening colonoscopies, the
European Society of Gastrointestinal Endoscopy (ESGE)
proposes that perforation should require surgery in ≤ 1/
1000 [57]. In an audit of post-colonoscopy complications
before starting national colorectal cancer screening, the
British Society of Gastroenterology (BSG) reported post-
colonoscopy perforation rates of 1/769 over a total of 9223
colonoscopies [58].
Statement 2
2.1.The maximum acceptable incidence of ICP for
diagnostic colonoscopies should not exceed 0.1%
(Recommendation Grade 1A).
2.2.During therapeutic colonoscopy, the maximum
acceptable incidence of ICP should be ≤ 1% for
complex polypectomy (Recommendation 1A) and less
than 7% for SEMS placement (Recommendation
Grade 1C).
Diagnosis of ICP
What is the minimum information the endoscopist must
report after diagnosing an ICP during a colonoscopy
procedure?
Perforation during diagnostic or screening endoscopic
procedures may occur from one of these two main path-
ways: (a) direct mechanical damage to the colonic wall by
the tip or the side of the endoscope as it is pushed forward
or (b) a pneumatic distension due to barotrauma (Table 4).
Direct mechanical trauma is the most frequent etiology of
ICP, and perforations originating from mechanical trauma
are commonly large and located in the sigmoid region.
The injury is usually produced by direct trauma due to an
inaccurate instrumental insertion, colonoscope move-
ments toward the mucosal surface, retro-flexion maneu-
vers, or excessive torsion. Indirect injuries can also occur
as the consequence of bowing or stretching the distal part
of the colon. The presence of redundant colon diverticula
or adhesions from previous surgeries can increase the risk
of mechanical trauma during colonoscopy [16]. Baro-
trauma is instead produced by the excessive distension of
the bowel due to over-insufflation, which produces linear
lacerations at the colonic wall that may evolve into full-
thickness defects. This type of perforation is more
frequently located at the cecal region, where the thinner
muscular layer and the larger lumen diameter make this
region more vulnerable to pressure-related injuries [6, 16,
59, 60]. For interventional endoscopies, the mechanism of
perforation can be the same as those occurring during
diagnostic endoscopy, or they may be due to thermal/elec-
trical injury of the colonic wall, manifesting as a wall
ischemia. In this latter case, the perforation can occur with
a delay of 24–72 h [18, 54]. Wall damage can be incom-
plete and the perforation concealed as it is confined by the
surrounding tissues. During the following days or weeks,
an abscess may develop that may delay the diagnosis.
Up to 60% of ICPs are detected by the endoscopist
while performing the procedure [14, 16, 18, 60–62]. In a
retrospective evaluation of a single institution, 68% of
ICPs were identified on the day of endoscopy, 23% on
day 1 or 2 after the endoscopy, and 9% were identified at
least 2 weeks after the procedure [29]. The results of a
survey of 30,336 colonoscopies showed a mean delay of
0.36 days for the diagnosis of ICP after diagnostic endos-
copies and 1.5 days after therapeutic procedures [5].
Statement 3
3.1.If the ICP is detected during the procedure by the
endoscopist, a detailed description should be
provided including the following information:
 Colonoscopy indication (i.e., diagnostic or
therapeutic)
 Associated colonic pathology (e.g., strictures,
polyps, tumors)
 Administration of sedation, analgesia, or
anesthesia for the colonoscopy
 Patient’s general status and presence of
comorbidities
 Gas type used for insufflation
 Quality of the colonic preparation
 Time of the ICP occurrence
 Most likely reason for ICP (e.g., thermal injury,
mechanical injury)
 Injury localization and size
 Whether an endoscopic resolution was intended,
attempted, or completed
 How the endoscopic repair was performed
 Presence of abdominal distention increasing the
probability of abdominal compartment syndrome
This recommendation was obtained by consensus
after discussion with the panel experts
(Recommendation Grade 2C).
Table 4 Main etiologies of iatrogenic colonoscopy perforation
(ICP)
Type of injury
• Direct mechanical trauma
• Barotrauma
• Thermal/electrical injury
Endoscopic therapeutic procedures at risk for ICP
• Colorectal stenting
• Polypectomy
• Colonic dilation
• Argon plasma coagulation (APC)
• Endoscopic mucosal resection (EMR)
• Endoscopic submucosal dissection (ESD)
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Which are the minimum biochemical and imaging
investigations that should be requested in the case of a
suspected ICP?
A delay in the diagnosis of ICP is a critical issue for thera-
peutic outcomes; when the diagnosis is delayed more than
24 h, the chance increases that more invasive treatments
(e.g., surgery) will be required [2, 63]. Physicians should
therefore search for this potentially life-threatening
complication and run clinical and biochemical tests if an
ICP is suspected.
An ICP can be appreciated by direct visualization of the
parietal defect or the view of intra-abdominal tissues
through the colonic wall during the endoscopy [15].
Otherwise, the diagnosis of ICP is based on clinical,
laboratory, and radiologic findings [64]. The clinical pres-
entation of an ICP can vary widely, depending on the size
of the perforation, the type of etiologic agent, the affected
colonic location, the degree of intra-peritoneal contamin-
ation, and the patient’s general status. In the majority of
patients (91–92%), symptoms develop within the first 48 h
following the completion of the endoscopy [14, 29]. The
most common symptom is abdominal pain associated
with distension, although painless cases of ICP or cases
with severe cramp-like pain have been described [13, 16,
18]. In two large clinical series, the most consistent symp-
toms were abdominal pain (from 74 to 95%), guarding/re-
bound tenderness (82.5) with diffuse peritonitis,
tachycardia (62.5%), leukocytosis (40%), fever (38%), rectal
bleeding (15%), and isolated abdominal distension (6.6%)
[16, 18]. Only a small number of patients with ICP (5%)
remained asymptomatic [52, 59]. An unusual clinical sign
(1/55 patients with ICPs) was a delayed subcutaneous em-
physema and an ongoing necrotizing infection of the ab-
dominal wall [16, 18]. It is a common belief that patients
with diffuse peritonitis can be diagnosed and treated for
perforation on a clinical basis, but peritonitis-like clinical
scenarios can also occur in the absence of perforation. For
instance, a transmural thermal injury after polypectomy
with serosal irritation without any obvious perforation
produces localized peritonitis that is amenable to non-
operative management. Thus, biochemical and imaging
studies are always indicated when an ICP is suspected.
Laboratory tests should be run for inflammatory
markers that can reveal severe bacterial infections asso-
ciated with the perforation [65], such as white blood cell
count (WBC) and C-reactive protein (CRP) [66, 67]. In
case of delayed presentation (> 12 h), the pro-calcitonin
level (PCT) can be useful for ICP diagnosis.
Perforations of intra-peritoneal segments of the colon
(e.g., the cecum, transverse colon, or sigmoid colon)
more often lead to free intra-peritoneal fluid and air
(large amounts in cases of barotrauma from insuffla-
tion), whereas perforations of the ascending and
descending colon and rectum or wall injuries contained
in the supplying mesentery result mainly in extra-
peritoneal air. Mixed situations are possible if the
perforation is in the middle between an intra- and
extra-peritoneal portion [68]. Upright or decubitus
abdominal radiographs can detect small amounts of
free peritoneal air, but they are insensitive to the pres-
ence of fluid. Plain thoracic and abdominal radiographs
have a positive predictive value (PPV) of 92% for ICPs
[13]. Of note, the PPV has been shown to be higher for
ICPs occurring during diagnostic procedures (PPV
100%) than for ICPs occurring during therapeutic pro-
cedures (PPV 45%) [2]. Alternatively, an ultrasound
may be useful in cases in which the radiation burden
should be limited, notably in children and pregnant
women. However, this method should not be consid-
ered definitive in excluding a pneumoperitoneum [69].
If the clinical suspicion of ICP persists after a normal
plain radiograph, a computed tomography (CT) scan
with contrast enhancement should be requested, as this
imaging tool can easily detect small amounts of both
free intra-peritoneal air and fluids, in some cases with
the foci of the gas congregating near the perforation
site [68]. Air trapped in the mesenteric folds is found in
perforation of the colon. A pneumoretroperitoneum is
caused by extraperitoneal perforations such as perfora-
tions of the descending colon and rectum. Gas in the
right anterior pararenal space indicates ascending colon
perforation, whereas gas in the left pararenal space
indicates descending or sigmoid colon perforations.
Generally, rectal perforation causes bilateral pneumore-
troperitoneum [70]. For extra-peritoneal perforations,
the CT scan can show air tracking along the mesenteric
and fascial planes, even in the mediastinum and
abdominal, and chest and neck walls. Of note, the
retro-peritoneal air dissecting the mediastinum and the
retropharyngeal tissues can cause a change in the tone
of the larynx, resulting in voice change [71].
Colonoscopy may also dissect within the wall of the
colon with pneumatosis. Moreover, mucosal injury and
intraluminal pressure may dissect air inside the mesen-
teric and portal venous system. For all these reasons,
CT is much more effective in the diagnosis of extra-
luminal air compared to conventional radiography [15].
Double contrast CT (intravenous and rectal) is increas-
ingly used in patients with clinical suspicion of ICP and
without diffuse peritonitis. This diagnostic tool may be
useful for detecting concealed or sealed perforations
that are eligible for non-operative management [72].
Multi-detector CT (MDCT) is superior to single helical
or conventional CT because it can provide rapid, high-
volume coverage, and diagnostic images, even in
patients who are unable to perform prolonged breath
holds. One study showed that MDCT was 86% accurate
in predicting the site of perforation [69].
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The following recommendations were developed using
a large clinical series and expert opinions, since random-
ized studies on this topic are lacking.
Statement 4
4.1.After diagnostic or therapeutic colonoscopies, all
patients who present with abdominal pain, and/or
tenderness, and/or abdominal distension, and/or
fever, and/or rectal bleeding should be investigated
for ICP by laboratory tests and imaging exams
(Recommendation Grade 1B).
4.2.The minimum biochemical markers that should be
requested in the case of suspected ICP are white blood
cell count and C-reactive protein (Recommendation
Grade 1C).
4.3.ICP should be confirmed with the demonstration of
free intra-peritoneal or extra-peritoneal air
(Recommendation 1B). CT scan is more sensitive
than standard abdominal radiographs to detect free
air (Recommendation Grade 1C).
4.4.In the case of localized peritoneal signs, double
contrast enhanced CT scan can be a useful
adjunctive tool to confirm the feasibility of
non-operative management of ICP (Recommendation
Grade 1C).
Conservative and endoscopic treatments for ICP
Which are the indications for conservative treatment or an
immediate surgical intervention after an ICP diagnosis?
Once the diagnosis of perforation is confirmed by clin-
ical and radiological examinations, the decision between
surgical and non-operative treatments will depend on
the type of injury, the quality of the bowel preparation,
the underlying colonic pathology, and the clinical stabil-
ity of the patient [6]. However, a surgical consultation
should be obtained in all cases of perforation [73].
Whenever the risk of a large perforation is present and
the patient presents with signs and symptoms of periton-
itis, the emergency surgery approach is reasonable and
safe [6]. Surgical management is also recommended in
patients with concomitant colonic diseases requiring
surgery, transplanted patients, and immunosuppressed
patients [36, 74]. In selected patients with localized pain,
free air without diffuse free fluids in radiographs,
hemodynamic stability, and an absence of fever, non-
operative management (conservative) may be appropriate
[61, 68, 75–78] and is associated with low morbidity, low
mortality, and short hospital stays. Conservative manage-
ment is usually suitable for small, sealed-off perforations
that occurred during a therapeutic colonoscopy in patients
with an optimal bowel preparation [8, 23, 24].
Conservative treatment consists of serial clinical and
imaging monitoring (every 3–6 h) with absolute bowel
rest, intravenous fluids for hydration, intravenous
administration of broad-spectrum antibiotics, and a
close multidisciplinary team follow-up to promptly
detect the development of sepsis and peritoneal signs [6,
78, 79]. Drainage of the peritoneal air through a Veress
needle punction may be useful in relieving abdominal
pain, improving respiratory function, and facilitating the
closure of the perforation site [80]. The overall success
rate of conservative treatments for colonic perforation
varies from 33 to 90% [36].
An early success with non-surgical treatment does not
rule out the potential need for surgery [52]. If the con-
servative treatment is successful, clinical improvement
will gradually occur within 24 h, but a continuous and
strict clinical and biochemical follow-up is recom-
mended. In cases of clinical deterioration or progression
to a septic condition or peritonitis, surgical treatment
should not be delayed. The sole presence of subdiaph-
ragmatic free air does not constitute an indication for
urgent surgery. Of note, complication rates and lengths
of hospital stay are significantly higher in patients who
have undergone surgery after conservative management
than in patients who were initially treated with surgery
[81]. Indeed, when surgical treatment is delayed, the
peritonitis and colonic wall inflammation could worsen,
requiring a more invasive surgery that is associated with
a poorer prognosis [13, 82]. Ideally, the decision to pur-
sue surgery should be made as early as possible after the
endoscopy [2].
Endoscopic treatment is possible when the perforation
site is recognized intra-procedurally or within 4 h follow-
ing the procedure and the bowel preparation is still
adequate [45]. Urgent endoscopic therapy with clip place-
ment and the use of CO2 may limit the volume of extra-
luminal insufflation and subsequently the need for surgery
[83–85]. Endoscopic clip closure of ICP was first reported
in the literature in 1997 [86]. Today, it should be consid-
ered a valuable non-invasive method for ICP that is recog-
nized during a colonoscopy. It has been shown to be
effective in sealing and healing the perforation and avoid-
ing surgery in most cases [2]. The decision to perform the
endoscopic closure of colonic perforation depends on the
size and the cause of the iatrogenic damage as well as the
endoscopist’s experience and the availability of appropriate
endoscopic devices [45]. Clipping closure of ICP is recom-
mended for small perforations (less than 1 cm) originating
from either diagnostic or therapeutic colonoscopies [2, 24,
87], with a success rate of 59–100% [2, 4, 88, 89]. In larger
or difficult perforations, a combination of endoclips and
endoloops might be used. There are also few reports in
the literature about closure with conventional clips for
perforations larger than 1 cm [90–92]. A limitation of the
endoscopic closure is the difficulty of evaluating the com-
pleteness of the colonic closure after the clip application.
This might result in delayed complications such as intra-
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abdominal abscesses, which can occur due to the persist-
ence of intestinal fluids in the peritoneal cavity or an inter-
mittent leakage [2].
Over the last several years, new devices have been intro-
duced to widen the spectrum of possibilities of performing
an endoscopic closure of a gastrointestinal perforation.
Through-the-scope (TTS) clips and over-the-scope clips
(OTSC) are both effective for the early closure of defects
smaller than 2 cm, with overall technical and clinical
success rates of 93 and 89%, respectively [88, 93–95]. TTS
clips are more suitable for closure of small therapeutic
perforations (less than 1 cm), whereas OTSC may be used
for larger defects. The OTSC is a nitinol clip shaped to
mimic a trap that allows for the inclusion of more tissue
and consequently closure of larger perforations than the
conventional clips [96]. Recent studies focusing on the
outcomes after OTSC placement revealed a rate of pro-
cedural success of 80–100% and clinical success rates of
57–100% [96–98].
The overstitch endoscopic suturing device (Apollo
Endosurgery, Austin, TX, USA) was recently developed
and might play a role in the future ICP closures [99].
Partially or totally covered stenting could potentially
allow closing the perforation, but data supporting its
clinical application are still lacking. A clear indication
for surgery in the setting of endoscopic treatment of an
ICP consists of a complicated procedure or a failed
endoscopic closure with an ongoing leak that is causing
fecal peritonitis [45].
Statement 5
5.1.Non-operative (conservative) management of ICPs
may be appropriate in selected patients, including
patients who are hemodynamically stable, without
sepsis, experiencing localized pain, and with no free
fluid in radiographs (Recommendation Grade 1C).
5.2.Endoscopic treatment can be considered as an initial
approach if it is feasible within 4 h following the
procedure depending on the size and cause of the
iatrogenic injury and the operator’s level of
experience (Recommendation Grade 2C).
5.3.Emergency surgery is recommended when the patient
develops signs and symptoms of peritonitis, in cases of
clinical deterioration, suspected large perforation,
failure of conservative management, poor bowel
preparation, or in the presence of an underlying
colonic disease requiring surgery (Recommendation
Grade 1A).
What is the minimum duration of the hospital observation
period for patients who have undergone successful
endoscopic closure or conservative management of ICP?
After a successful endoscopic closure, it is advisable that
a multidisciplinary team, including abdominal surgeons,
endoscopists, gastroenterologists, and anesthesiologists,
are involved in the patient’s follow-up [52]. Fasting,
broad-spectrum antibiotic therapy and intravenous
hydration are the basis of treatment [3, 88, 100]. Close
observation for signs of peritoneal irritation and moni-
toring of biochemical inflammatory parameters are
crucial. When pain disappears and the inflammatory
parameters and bowel function return to normal, oral
intake can be resumed [100]. The duration of observa-
tion is subjective but obviously related to the patient’s
status and the response to the conservative (non-opera-
tive) or endoscopic treatment. The mean duration of
hospital stay after non-surgical ICP management ranges
from 9 to 13 days [88].
Statement 6
6.1.After conservative or endoscopic treatment of ICP,
monitoring and follow-up should be assured by a
multidisciplinary team, including surgeons. There is
no optimal duration of the observation period, but it
depends on the patient’s clinical status and response
to treatment (Recommendation Grade 1C)
Which investigations (clinical, biochemical, and imaging)
should be performed during the observation period in
patients who have undergone successful endoscopic closure
or conservative management of ICP?
There are no studies in the literature focusing specific-
ally on the clinical and biochemical follow-up of patients
who have undergone endoscopic closure or conservative
management of ICP.
The available evidence is mainly supported by retro-
spective series. During the observation period, the
patient treated for ICP should be monitored clinically as
well as through laboratory values and imaging. Clinically,
peritoneal signs such as tenderness, rebound tenderness,
and muscle guarding, as well as signs of infection, such
as fever, nausea, vomiting, abdominal distension, and
diarrhea, should be recorded [36, 69]. Frequent assess-
ment of the physical status and vital signs should be
completed by laboratory tests for WBC, CRP, Hb, blood
urea nitrogen, PCT, and electrolytes [66]. As an imaging
technique, the CT scan remains the most accurate tool
to be performed in case of clinical deterioration, espe-
cially when the need for surgery is in question and
before discharge for non-operative treatments.
Statement 7
7.1.During the observation period, the patient treated
for ICP should be monitored clinically, by laboratory
tests (including WBC, PCT, CRP) and imaging (CT
scan) (Recommendation Grade 2C).
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What is the recommended type and duration of antibiotic
therapy in patients who have undergone successful
endoscopic closure or conservative management of ICP?
In patients who have undergone endoscopic repair of
ICP, infection control is usually attained with a short-
term course of antibiotic therapy (3–5 days). Antibi-
otics should be stopped if there are no signs of systemic
inflammation and/or peritonitis after the short-term
treatment. Considering the composition of the intes-
tinal microbiota in the large bowel, patients with ICP
require antimicrobial coverage for Gram-negative bac-
teria as well as for anaerobes. The potential infecting
organisms in colorectal procedures are derived from
the bowel lumen, where Bacteroides fragilis and other
obligate anaerobes as well as Enterobacteriaceae such
as Escherichia coli are the most common bacteria [101].
If there is any sign of an ongoing infectious process,
antibiotics should be continued. An abdominal CT is
recommended after 5–7 days to exclude residual signs
of peritonitis or abscess formation and to exclude the
possible need for a surgical intervention.
The duration of antimicrobial therapy in patients with
complicated intra-abdominal infections has been debated.
Antibiotic therapy should be shortened in those patients
demonstrating a positive response to treatment. A pro-
spective trial published recently by Sawyer et al. demon-
strated that, in patients with complicated intra-abdominal
infections undergoing an adequate source-control proced-
ure, the outcomes after approximately 4 days of fixed-
duration antibiotic therapy were similar to those after a
longer course of antibiotics that extended until after the
resolution of physiological abnormalities [102].
Statement 8
8.1.In patients who have undergone conservative
management of ICP, even if there is no sign of diffuse
peritonitis, antibiotic therapy covering Gram-negative
bacteria and anaerobes is recommended
(Recommendation Grade 1C).
8.2.In patients with perforation repaired by endoscopic
closure, a short-term course of antibiotic therapy
(3–5 days) covering Gram-negative bacteria and
anaerobes is recommended. Antibiotics should be
stopped if there are no signs of systemic inflammation
and/or peritonitis after the short-term treatment.
Abdominal CT is suggested to help rule out
peritonitis or early abscess formation
(Recommendation Grade 1C).
8.3.In patients who have undergone a surgical procedure
with an adequate source-control procedure,
postoperative therapy should be shortened as much
as possible after the resolution of physiological
abnormalities (Recommendation Grade 1C).
Which is the recommended type and duration of
antithrombotic prophylaxis in patients who have
undergone successful endoscopic closure or conservative
management of ICP?
Sepsis is associated with activation of blood coagulation
(hypercoagulability) contributing to venous thrombo-
embolism (VTE) [103–105]. Patients with abdominal
sepsis may be at increased risk of VTE due to their
premorbid conditions, surgical intervention, admitting
diagnosis of sepsis, and events and exposures such as cen-
tral venous catheterization, invasive tests and procedures,
and drugs that potentiate immobility. A prospective
cohort study using the National Surgical Quality Improve-
ment Program database of the American College of Sur-
geons (ACS-NSQIP) was designed to evaluate the impact
of preoperative sepsis on the risk of postoperative arterial
and venous thrombosis. The study included 2,305,380
adults who underwent a range of surgical procedures
[106]. The systemic inflammatory response syndrome was
defined by the presence of two or more of the following:
temperature > 38 or < 36 °C; heart rate > 90 beats/min; re-
spiratory rate > 20 breaths/min or a PaCO2 < 32 mmHg
(< 4.3 kPa); white blood cell count > 12,000 cells/mm3, <
4000 cells/mm3, or > 10% immature band forms; or anion
gap acidosis (> 12 mEq/L). Among all surgical procedures,
patients with preoperative systemic inflammatory
response syndrome or any sepsis had three times the odds
of having an arterial or venous postoperative thrombosis.
The risk of thrombosis increased with the severity of the
inflammatory response and was higher in both emergent
and elective surgical procedures. Thus, patients with ICP
should be considered at risk, and thromboprophylaxis
should be recommended.
Statement 9
9.1.In patients with ICP undergoing a surgical
procedure, thromboprophylaxis is generally
recommended during hospitalization and thereafter
according to the underlying disease and comorbidities
(Recommendation Grade 1B).
How long is it recommended that patients fast following
successful endoscopic closure or conservative treatments
for ICP?
There are no prospective clinical trials assessing the
necessary duration of fasting following non-operative
management or endoscopic repair of ICP. In the setting of
conservative treatment, the general recommendations
called for “bowel rest,” but the duration is unclear. Retro-
spective studies reported fasting durations of between 2
and 6 days. In one of the largest series, 24 patients with
ICP were managed with conservative treatment, which
failed in 3 patients; 31 patients were initially clipped, of
which 22 procedures were successful. Poor outcomes were
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related to patient age, ASA status, and failure of conserva-
tive treatment. The only significant predictor of failure of
the conservative treatment was the perforation size. Fast-
ing duration did not appear to impact the outcomes [81].
Park et al. [69] reported a single-center series on ICP
including 15 patients managed with either conservative
treatment (n = 4) or endoscopic repair (n = 11) and com-
pared these patients with 35 patients managed surgically.
The duration of fasting was significantly shorter in the
non-surgery group than in the surgery group (3.8 vs.
5.6 days). The mean fasting time was also 1 day shorter
for patients treated by endoscopic repair versus surgery in
the study by Kim et al. [4]. Moreover, the fasting duration
was not related to ICP treatment failure.
It has been suggested that a clear liquid diet can begin
immediately after the endoscopic repair of ICP; the evi-
dence is not strong, but there are no data to indicate that
this practice is not feasible or unsafe [36]. Following open
or laparoscopic repair of ICP, there is no restriction on
oral intake, as supported by numerous studies that pro-
vided enteral nutrition in the early period after colorectal
surgery [107].
Statement 10
10.1.A liquid diet may begin within 1 to 2 days after the
initiation of conservative management of ICP,
according to the patient’s clinical status
(Recommendation Grade 1C)
10.2.A liquid diet may begin immediately after
endoscopic repair of ICP, according to the patient’s
clinical status (Recommendation Grade 1C)
Surgical treatment of ICP
Is explorative laparoscopy indicated in all patients with ICP?
Surgery is indicated as the first treatment in patients
with ongoing sepsis, signs of diffuse peritonitis, large
perforations, and failure of conservative management
and in the presence of certain concomitant pathologies,
such as unresected polyps with high suspicion of being a
carcinoma [6, 60, 78].
The peri-operative morbidity and mortality related to
surgery for ICP are considerable, with rates of 21–44%
and 7–25%, respectively [5, 13–18]. Particularly frail
patients, such as older patients and patients with low
preoperative blood pressure, can have higher risks of
mortality associated with colorectal perforation [108].
Thus, appropriate patient selection and surgical proce-
dures are crucial in limiting the morbidity and mortality
related to surgery for ICP.
In general, intraoperative findings determine the best
technique to apply according to the different scenarios.
Surgical procedures for the management of ICP include
colorraphy, wedge resection, colostomy by exteriorization
of the perforation, and colonic resection with or without
primary anastomosis or stoma. The decision regarding the
type of surgical procedure depends on (a) the size,
location, and etiology of the ICP; (b) the viability of the
surrounding colon and mesocolon; (c) the degree of and
time from the development of peritonitis; (d) the patient’s
general status and the presence of comorbidities; (e) the
quality of the colonic preparation; and (f) the presence of
residual lesions not resected during the colonoscopy
procedure [2, 8, 24, 60, 82, 109, 110].
The decision of which procedure to perform, therefore,
depends on many variables, and it must be made after a
careful inspection of the whole colon and peritoneal cavity.
Explorative laparoscopy should be considered a minimally
invasive technique useful for performing both diagnostic
and potentially therapeutic procedures. A timely application
of explorative laparoscopy may prevent ongoing inflamma-
tion and injury that would necessitate more invasive mea-
sures, such as open laparotomy and/or colonic diversion
[82]. The use of laparoscopy allows for visualizing the
parietal defect and its size and specific location, as well as
for identifying the potential cause of the perforation (e.g.,
perforation caused by the shaft of the endoscope, cautery,
presence of mesenteric hematomas, emphysema, or
effusions), which, as previously stated, are the main factors
influencing the choice of treatment option. Early diagnosis
is mandatory, and when timely management is ensured,
laparoscopy can be the best option, offering reduced mor-
bidity and length of stay and faster postoperative recovery.
If no underlying lesion requiring surgical resection is seen
during the endoscopy, the size of the tear is small, and the
colon is healthy and well perfused, then a laparoscopic
primary repair can be safely performed [52, 111].
Moreover, laparoscopic exploration allows the pres-
ence of potential signs of peritonitis to be evaluated and
eventually allows aspiration, culture, and irrigation of
the peritoneal cavity to be performed. Indeed, peritoneal
washout and drainage have gained acceptance in the
treatment of more advanced cases of colonic infection,
such as Hinchey grade 2–3 diverticulitis [112]. Accord-
ingly, the treatment of less advanced inflammatory
processes, such as ICP, seems reasonable and indicated.
To summarize, explorative laparoscopy is indicated:
 For both diagnostic and therapeutic purposes [5, 9,
13, 17, 52, 100, 109, 113–119], and depending on
the surgeon’s skills, the potential exists for definitive
surgical procedures, including suturing the defect,
wedge resection, and segmental resection with or
without anastomosis and/or stomia
 In questionable situations to rule out the need for
further treatments, including laparotomy [82, 118, 120]
 In the case of failure of endoscopic treatment or an
inability to perform endoscopic clip application after
visualization of the ICP intra-procedurally
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 In the case of development of peritonitis after a
defined period of observation following perforation
Explorative laparoscopy has a significantly lower
morbidity and mortality compared with explorative
laparotomy in the emergency setting [121]: specifically,
the reported postoperative complication rate is 18.2% for
laparoscopy vs. 53.5% for laparotomy. The postoperative
mortality rate is 1.11% for laparoscopy vs. 4.22% for
laparotomy; and the need for further procedures is
significantly lower for laparoscopy (1.11%) than for
laparotomy (8.45%).
Explorative laparoscopy may not be indicated when
there is:
 A potential risk for anesthesia-related complications,
particularly in elderly or frail patients [122, 123], or
any contraindications to surgery in general (e.g.,
hemodynamic instability, coagulopathy, or associated
co-morbidities) [9, 122, 123]
 Recent laparotomy or previous abdominal surgery
(more than 4 laparotomies) with extensive adhesions
and a high risk of iatrogenic injury (relative
contraindication)
 The presence of massive bowel dilatation (relative
contraindication)
 Aorto-iliac aneurysmal disease (relative
contraindication)
The potential diagnostic/therapeutic value of
explorative laparoscopy should also be compared with
the role of a CT scan in the evaluation of ICP. There
is no study in the literature focusing on whether
explorative laparoscopy should be performed instead
of CT scans in patients with highly suspected ICP.
However, when comparing these two modalities for
penetrating abdominal trauma, CT scans have a sensi-
tivity/specificity rate of 95%/95%, whereas explorative
laparoscopy can achieve a 67–100% sensitivity and
50–100% specificity [121]. Thus, a CT scan should be
performed in all cases before contemplating explora-
tive laparoscopy, with the only obvious impediment
being hemodynamic instability.
Statement 11
11.1.Explorative laparoscopy is safe and can be
considered as the preferred first-line surgical
approach for the management of ICP
(Recommendation Grade 1C).
11.2.Explorative laparoscopy should be performed
according to the surgeon’s experience and skills, as
well as the availability of adequate technology and
surgical devices (Recommendation Grade 1C).
Which are the indications for conversion from laparoscopy
to open surgery in patients with surgical ICP?
Thanks to the improvements in minimally invasive sur-
gery, the laparoscopic approach has been increasingly
used in recent years, and it should currently be considered
a safe and feasible technique for the management of ICP
[9, 24, 82, 113, 124–126]. Current literature comparing
outcomes of laparoscopy versus laparotomy for the treat-
ment of ICP is scarce and consists mainly of small retro-
spective studies. The first relevant study was published in
2008 [110] and compared the perioperative outcomes
between laparoscopic and open procedures for ICP by
including only primary colonic closures without diversion.
The authors found fewer complications and a shorter
length of hospital stay for the patients in the laparoscopic
group [110]. Other studies by Rothold et al. [125] and
Schloricke et al. [127] also observed fewer postoperative
complications and significantly shorter hospital stays
when utilizing the laparoscopic approach. Similar studies
with similar results were published by Coimbra et al. [124]
and Kim et al. [128], although in these studies, delayed
surgeries (> 24 h) and ostomy formation rates were more
frequently observed in the open groups, with higher
primary repair rates in the laparoscopic groups.
Due to its favorable short-term outcomes, laparoscopy
should be considered the preferred approach for both
exploration and repair of ICPs that are not manageable
with medical treatments. However, the surgeon’s experi-
ence and skills are the key factors limiting the applicabil-
ity and feasibility of laparoscopic ICP management.
Conversion from laparoscopy to laparotomy should be
considered whenever necessary. The most frequent
reasons for conversion are the inability of the surgeon to
complete the procedure laparoscopically, the large size
of the ICP defect, the extensive peritoneal contamin-
ation, the highly inflammatory or neoplastic conditions
of the colon, and the patient’s hemodynamic instability.
Statement 12
12.1.Conversion from laparoscopy to laparotomy should
be considered whenever necessary with regard to the
ability of the operator to proceed laparoscopically,
the tissue viability, and the patient’s status
(Recommendation Grade 1C).
What are the key factors upon which to choose the best
surgical approach for ICP?
The choice of the surgical approach and technique
mainly depends on the underlying pathology (e.g., colon
cancer, diverticulitis) and the size of the ICP. Primary
surgical repair can be used if the colonic tissue appears
healthy and well vascularized and if suturing the perfor-
ation edges could be performed without tension [24,
113]. Wedge resection is feasible if it does not imply an
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excessive narrowing of the colonic lumen (e.g., cecum)
[108]. Whenever the perforation is too large, the edges
appear devitalized, or an avulsion of the adjacent meso-
colon is seen, colonic resection might constitute the best
option. Generally, patients who undergo surgery within
24 h are more appropriate candidates for less invasive
techniques, such as primary suturing of the defect or lin-
ear wedge resection. In cases of delayed surgery (> 24 h
from the colonoscopy), extensive peritoneal contamin-
ation, important comorbidities, or a deterioration of the
general status of the patient (i.e., sepsis), a staged repair
or colostomy by exteriorization of the perforation (e.g.,
double-barreled colostomy) must be considered [36, 52].
Currently, there are no prospective or retrospective
studies in the English literature comparing the different
types of repair (primary suture or wedge resection vs.
segmental resection). Therefore, the choice of the surgi-
cal technique appears to be mainly empirical, and it is
left to the surgeon’s discretion according to the intraop-
erative findings. Independent of the surgical approach,
the main goal of the therapy is the rapid diagnosis,
repair, and prevention of abdominal sepsis. If an ICP is
to be repaired laparoscopically, the operating surgeon
and the surgical team should be comfortable with the
laparoscopic techniques, such as mobilization of the
colon and intracorporeal suturing. A clinical algorithm
mainly based on the size of the perforation and the nec-
rotic area was proposed in 1999 to assist in choosing
which type of repair to perform [8]. The maximal size
for sutured repair was set at 1 cm. Between 1 and
2.5 cm, a transverse tangential stapled resection was
recommended, whereas above 2.5 cm, a segmental resec-
tion was indicated [8, 129]. The condition of the bowel
to be repaired and the level of contamination and
inflammation are the most important factors in deter-
mining whether the laparoscopic approach is safe [109].
Both sutured and stapled repair techniques seem to be
safe and feasible to repair defects of up to 4 cm [82].
In case of perforated colon cancer, surgery must follow
the oncologic principles of cancer resection.
Statement 13
13.1.The best surgical technique for the management of
ICP should be decided after a careful inspection of
the abdominal cavity and considering the underlying
colonic pathology (Recommendation Grade 2C).
13.2.Primary repair can be used if the colonic tissues
appear healthy and well vascularized, and an
approximation of perforation edges could be done
without tension (Recommendation Grade 2C).
13.3.Wedge resection would be feasible if it does not
imply an excessive narrowing of the colonic lumen
(e.g., perforation of the cecum or sigmoid colon)
(Recommendation Grade 2C).
13.4.Colonic resection may be indicated if the
perforation is too large, the edges appear devitalized,
or an avulsion of the adjacent mesocolon is seen
(Recommendation Grade 2C).
13.5.Staged repair or colostomy may be necessary in
cases of delayed surgery (> 24 h from the
colonoscopy), extensive peritoneal contamination,
important comorbidities or a deterioration of the
patient’s general status (i.e., hemodynamically
unstable or sepsis) (Recommendation Grade 2C).
What are the indications for performing a diverting or
terminal stoma in patients with ICP?
The formation of a stoma is often included in the overall
surgical strategy for the management of ICP. However,
no randomized controlled trials or other high-level
evidence trials exist to guide this operative decision in
this specific indication. Case series of ICP report variable
rates of stoma formation (up to 59.7%) [59, 114, 116,
126, 130]. As such, the formation of a stoma forms an
adjunct to the overall treatment strategy for these
patients.
The precise clinical or operative reasons for stoma for-
mation are incompletely reported in the case series on
ICP. Furthermore, these reports are generally limited by
their largely retrospective study designs and low event
numbers, complicating subgroup analyses. Notwith-
standing these limitations, some authors have estab-
lished increased stoma formation rates in patients with
delayed diagnoses, significant peritonitis, and patients
with left-sided perforations [114, 126]. Apart from these
observations, the limited publications in this area infer
that surgical judgment remains essential in the decision-
making surrounding the formation of a stoma. Finally,
no data exist to specifically address the type of stoma
formation in ICP.
Statement 14
14.1.Stoma formation is an accepted and practiced
adjunct in the surgical management of ICP
(Recommendation Grade 1C).
14.2.Surgical judgment is crucial in the decision
regarding stoma need: patient, disease, and
situational/environmental factors need to be
considered in the individual clinical circumstance
(Recommendation Grade 1C).
What are the indications for drainage in patients with ICP?
The placement of an intra-abdominal drainage after sur-
gical management of an ICP can be justified by either
the presence of peritoneal contamination or the early
diagnosis of a potential bleeding or leakage of the repair
used for the perforation (i.e., colorraphy, wedge resec-
tion, colonic resection) [131–133]. There are no studies
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available in the literature focusing on the indications of
abdominal drainage after successful surgical treatment of
ICP. The decision is left to the discretion of the surgeon
according to the ICP setting, the intraoperative findings,
the type of surgical procedure performed, the adequate-
ness of infection source control, and the patient’s general
status [5, 14, 108].
Statement 15
15.1.In the case of early surgery (< 24 h from
colonoscopy) in a patient with good bowel
preparation, minimal peritoneal contamination, and
adequate infection source control, intra-abdominal
drainage placement should be avoided
(Recommendation Grade 2C).
15.2.In the case of delayed surgery (> 24 h from
colonoscopy) in a patient with poor bowel
preparation or extensive peritoneal contamination,
drainage placement may be recommended
(Recommendation Grade 2C).
What are the indications for the use of damage control
surgery in patients with ICP?
At present, no study concerning ICP and damage control
surgery (DCS) is available in the literature. However, once
colonic perforation has occurred, the course of sepsis will
develop independent of the underlying disease. Thus, to
evaluate the use of DCS in cases of ICP, we could analyze
the experience in similar settings, such as in perforated
diverticulitis (PD), equating ICP to PD [134, 135].
Damage control is a surgical technique originally used
in trauma surgery consisting of three stages: (1) an ab-
breviated initial laparotomy with the aim of controlling
hemorrhage and contamination with temporary abdom-
inal closure (TAC); (2) resuscitation until normal physi-
ology is improved; and (3) return to the operating room
after 24–72 h for definitive injury repair and abdominal
wall closure [136–138].
Untreated or misdiagnosed ICP can progress to peritonitis
and sepsis, resulting in serious morbidity and a very poor
prognosis. Notably, morbidity rates as high as 43% and mor-
tality rates as high as 25% have been reported [17, 20, 36,
50, 60, 139]. Nearly one quarter of patients will receive a de-
layed diagnosis, with a 45% incidence of fecal peritonitis
[140]. The resultant inflammatory process associated with
peritonitis clearly limits the operative options, precluding a
single-stage procedure and resulting in fecal diversion in
38% of patients with fecal peritonitis. Several studies
reported that age > 67 years, ASA score, blunt injuries, poor
bowel preparation, and steroids are risk factors for increased
postoperative morbidity (Table 5) [20, 123, 141, 142].
Over the last decade, DCS has become a valuable tech-
nique in unstable patients with fecal peritonitis [36, 136,
143]. The potential progression of ICP in fecal peritonitis
is as probable as it is in perforated diverticulitis. In accord-
ance with the WSES guidelines for the management of
acute left-sided colonic diverticulitis, DCS may be sug-
gested for clinically unstable patients (severe sepsis/septic
shock) [135]. Critically ill patients with severe sepsis,
hemodynamically unstable patients with hypotension, and
patients with myocardial depression combined with coag-
ulopathy are not candidates for endoscopic treatment or
immediate complex operative interventions. In such
patients, DCS allows rapid source control, enhances
physiologic optimization, improves primary anastomosis
rates, and decreases the need for stoma formation [144].
Therefore, in patients with abdominal sepsis, the applica-
tion of DCS is individualized but not routinely used, as
suggested by current clinical guidelines [145], stressing
the importance of a careful assessment by the surgeons.
Clearly, an individual approach tailored to each patient’s
clinical status might be the most appropriate. In cases of
ICP, DCS should be performed in combination with the
resection of the perforated colonic segment to bridge the
patient to the definitive injury and colonic continuity re-
pair. DCS can represent a very resource-heavy procedure
for institutions, however, because of the requirements for
access to facilities (operating rooms and intensive care
units) and committed staff.
Statement 16
16.1.DCS following ICP may be indicated in
hemodynamically unstable patients, patients
receiving a delayed diagnosed of ICP, and patients
Table 5 Risk factors to evaluate when considering damage control strategy for iatrogenic colonoscopy perforations (ICP)
Risk factors Description References
Age > 67 [140]
Delayed diagnosis > 24 h [140, 142]
Hemodynamic instability Need for vasopressors before or during surgery [123, 143]
“Blunt” ICP Perforation caused by excessive dilatation or during diagnostic procedures [142]
Medication use Chronic steroid therapy [13, 140]
Severe sepsis Peritonitis with organ failure [135, 141]
High surgical risk ASA III and IV [142]
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presenting with significant comorbidities
(Recommendation Grade 2C).
16.2.DCS can be a valid option in cases of staged
procedures, particularly when oncologic resections are
required (Recommendation Grade 2C).
Follow-up of ICP
Is there any recommendation to perform a surveillance
endoscopy after successful ICP treatment? If any, what is
the recommended timing for it?
At present, there are no studies in the literature focusing
on the indications and timing for surveillance endoscopy
after successful ICP treatment. However, based on the
available evidence and clinical experience, a surveillance
colonoscopy may be performed based on the initial indi-
cation (e.g., benign or malignant pathology) and type
(e.g., screening or interventional) of the primary colon-
oscopy (during which the ICP occurred) and considering
the risk-benefit ratio of performing an endoscopic exam
[146, 147].
Colonoscopy is specifically contraindicated in cases of
known or suspected perforation [148]. Consequently,
any endoscopy after ICP treatment should be performed
once the colonic wall has completely healed. Assuming
that the healing time after ICP treatment is comparable
to that after surgical sutures or anastomosis, a surveil-
lance endoscopy may be indicated after approximately
3 months from the successful ICP treatment, depending
on the size of the perforation and the type of repair
[149].
In general, prior to any surveillance colonoscopy, it is
necessary to carefully re-evaluate the presence of specific
conditions favoring perforation, including increasing age,
female gender, low BMI, intensive care unit stay,
inpatient setting, diverticular disease [150], Crohn’s
disease [30], obstruction as an indication for the primary
colonoscopy, and invasive interventional colonoscopy
[26]. Indeed, colonoscopy is contraindicated whenever
the risks for the patient’s health or life are judged to
outweigh the most favorable benefits of the procedure
[148].
Statement 17
17.1.In cases of perforation occurring during a diagnostic
colonoscopy for screening or surveillance of colorectal
cancer, a repeat endoscopy is indicated within 3 to
6 months postoperatively if the screening or clearing
colonoscopy was incomplete due to malignant
obstruction or inadequate preparation
(Recommendation Grade 1C).
17.2.In cases of perforation occurring during a
colonoscopy for gastrointestinal bleeding, a
surveillance endoscopy is indicated for diagnostic and
therapeutic purposes; in cases of acute lower
gastrointestinal bleeding, it is necessary to ascertain
the resolution of the perforation (Recommendation
Grade 1C).
17.3.In cases of perforation occurring during an
operative colonoscopy (e.g., polypectomy, endoscopic
mucosal resection, or endoscopic submucosal
dissection), a surveillance colonoscopy should be
performed according to the current guidelines to
determine whether the resection during the primary
endoscopy was complete. The surveillance endoscopy
can be performed within 3 to 6 months from the
operative colonoscopy during which the ICP occurred
in cases of incomplete resection (Recommendation
Grade 1C).
Conclusions
Iatrogenic perforation is a potentially severe complica-
tion of colonoscopy that requires a prompt and specific
treatment to avoid further morbidity and mortality. In
general, a multidisciplinary management, involving
gastroenterologists, endoscopists, surgeons, and anesthe-
siologists, is recommended. The treatment strategy must
be chosen based on the clinical setting and the patient’s
characteristics, but it should also be adapted to the
medical team’s experience and local resources. The
comprehensive algorithm presented in Fig. 2 summarizes
the management strategies in cases of ICP.
The risk of ICP should be carefully evaluated before a
procedure; whenever a risky endoscopy must be
performed, the availability of a hospital-based multidis-
ciplinary team can improve patient outcomes. Continu-
ous monitoring and auditing of endoscopic standards
and related complications is recommended in each
endoscopic center to detect possible performance gaps
and improve the safety of colonoscopy. Close collabor-
ation between endoscopists and surgeons is advisable;
whenever an ICP occurs, the endoscopist is expected to
provide a detailed description of the perforation, proced-
ure, and patient to determine the best treatment option.
Endoscopic repair should be attempted whenever the
perforation is detected during the procedure, though
outcomes depend on the size and cause of the iatrogenic
injury, as well as on the operator’s level of experience.
When the ICP is not immediately detected, it should
be suspected and investigated in all patients who present
with abdominal pain, tenderness, abdominal distension,
fever, and/or rectal bleeding after a diagnostic or thera-
peutic colonoscopy. CT scan is the most accurate
imaging tool to diagnose ICP. Non-operative (conserva-
tive) management may be appropriate in selected
patients who remain hemodynamically stable in the
absence of signs of sepsis. Conservative management
consists of complete bowel rest, short-course broad-
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spectrum antibiotics and intravenous hydration together
with close clinical observation.
It must be stressed that early improvement with con-
servative treatment does not rule out the potential need
for surgery. Close monitoring of the patient will allow
detection of clinical deterioration, which may signal the
need for emergency surgery. Where surgical intervention
is required, timely decisions for proceeding with the op-
eration are important. Ideally, these surgeries should
occur early and within 24 h of the perforation, as further
delays are related to a worse prognosis.
Colonic closure, wedge resection, ostomy, and colonic
resection are the main surgical options for ICP manage-
ment. No RCTs have assessed the superiority of one
method over the others. Thus, the therapeutic decision
remains essentially empirical, based on the perforation
characteristics (e.g., size, time of evolution, and degree
of peritoneal contamination), the patient’s general status
(e.g., comorbidities), and the availability of adequate
technology and surgical devices. Explorative laparoscopy
is safe and should be considered the first line approach
to assess the perforation-related damages. In patients
with good bowel preparation, minimal peritoneal
contamination, and adequate infection source control,
the perforation repair can possibly be performed by
laparoscopy and without drainage placement. Alterna-
tively, staged repair or, in extreme cases, damage control
surgery may be required.
The present WSES guidelines contribute to clarifying
the complex decision-making process for the manage-
ment of ICP. Despite the large number of publications,
evidence is often derived from observational and moder-
ate to low quality studies. However, it is scarcely feasible
to design RCTs for an infrequent complication often
requiring emergency treatment. Prospective registries
would be highly advantageous to defining the validity of
the present recommendations and proposed guidelines.
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